Shares of RegeneRx Biopharmaceuticals Inc. (OTCMKTS:RGRX – Get Free Report) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.09 and traded as low as $0.00. RegeneRx Biopharmaceuticals shares last traded at $0.00, with a volume of 2,476 shares trading hands.
RegeneRx Biopharmaceuticals Stock Performance
The business has a 50-day moving average of $0.09 and a two-hundred day moving average of $0.04.
RegeneRx Biopharmaceuticals Company Profile
RegeneRx Biopharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for the treatment of dermal wounds and reduction of scar tissue.
Featured Articles
- Five stocks we like better than RegeneRx Biopharmaceuticals
- 5 Top Rated Dividend Stocks to Consider
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- How to Choose Top Rated Stocks
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
- Why Invest in 5G? How to Invest in 5G Stocks
- This Defense Stock Has a $57B Backlog and New AI Tailwinds
Receive News & Ratings for RegeneRx Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RegeneRx Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
